Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | unknown | PO / MO |
The patient took only three of four doses month ago; Case reference number US-BN-2025-001010 is a spontaneous case initially received from pharmacist via Communication (reference number: USBAV25-1318) on 04-Jun-2025 and concerns a female patient with unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified dates also reported as month ago, the patient took three doses of Vivotif, and did not take the fourth dose yet (batch number: unknown) orally, at unknown dose, for travel immunisation (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of initial report, it was unknown if patient experienced any adverse event due to Vivotif. No further information was provided.; Reporter's Comments: A female patient with unspecified age took three doses of Vivotif (reportedly one month ago), and did not take the fourth dose yet which is currently considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A female patient with unspecified age took three doses of Vivotif (reportedly one month ago), and did not take the fourth dose yet which is currently considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company convention. At this point, it was unknown if patient experienced any adverse event due to Vivotif. The patient's medical history and concomitant medication details were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None